HP Inc
HPQ
32.24
+0.51
+1.61%
HP Inc
US · HPQ
#712 by market cap
Listed 1970
32.24
+0.51
+1.61%
Live - 5344 symbols - heartbeat 136s ago
· 2026-10-08 07:42
Pre-market
32.24
0.00%
After-hours
32.44
+0.62%
Overnight
32.08
-0.50%
- Market cap
- 29.07B
- P/E (TTM)i
- 12.31
- P/Bi
- -316.08
- EPSi
- 2.65
- Div yieldi
- 3.69%
- 52W posi
- 79%
Reader sentiment
Are you bullish or bearish on HPQ?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.76, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.24% YoY
Margins
- Gross margin
- 20.60%
- Operating margin
- 6.55%
- Net margin
- 4.57%
Key ratios & quality
- Enterprise valuei
- 35.45B
- Altman Z-Scorei
- 1.76
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 58.47B | 58.76B | 56.64B | 63.46B | 62.91B | 53.72B | 53.56B | 55.30B |
| Gross profit | 10.67B | 11.17B | 10.42B | 13.41B | 12.26B | 11.51B | 11.82B | 11.39B |
| Selling & admin expenses | 5.10B | 5.37B | 4.90B | 5.73B | 5.26B | 5.36B | 5.66B | 5.82B |
| Research & development | 1.40B | 1.50B | 1.48B | 1.85B | 1.65B | 1.58B | 1.64B | 1.60B |
| Operating profit | 3.42B | 3.00B | 3.93B | 5.68B | 5.12B | 4.22B | 4.20B | 3.62B |
| Pretax profit | 3.01B | 2.52B | 3.21B | 7.57B | 4.32B | 2.94B | 3.28B | 2.67B |
| Tax | -2.31B | -629.00M | 396.00M | 1.03B | 1.19B | -326.00M | 504.00M | 139.00M |
| Net profit | 5.33B | 3.15B | 2.82B | 6.54B | 3.13B | 3.26B | 2.78B | 2.53B |
| Basic EPS | 3 | 2 | 2 | 5 | 3 | 3 | 3 | 3 |
| Diluted EPS | 3.26 | 2.07 | 1.98 | 5.36 | 2.98 | 3.26 | 2.81 | 2.65 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 13.22B | 13.93B | 14.64B | 14.44B | 14.41B | 15.68B |
| Gross profit | 2.74B | 2.85B | 2.96B | 2.84B | 3.02B | 2.95B |
| Selling & admin expenses | 1.48B | 1.45B | 1.43B | 1.50B | 1.51B | 1.54B |
| Research & development | 401.00M | 406.00M | 398.00M | 392.00M | 432.00M | 389.00M |
| Operating profit | 793.00M | 834.00M | 1.08B | 883.00M | 981.00M | 944.00M |
| Pretax profit | 506.00M | 624.00M | 834.00M | 671.00M | 493.00M | 798.00M |
| Tax | 100.00M | -139.00M | 39.00M | 126.00M | 43.00M | 137.00M |
| Net profit | 406.00M | 763.00M | 795.00M | 545.00M | 450.00M | 661.00M |
| Basic EPS | 0 | 1 | 1 | 1 | 0 | 1 |
| Diluted EPS | 0.42 | 0.80 | 0.84 | 0.58 | 0.49 | 0.71 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 21.39B | 20.18B | 20.65B | 22.17B | 19.74B | 17.98B | 20.76B | 22.45B |
| Cash & ST investments | 5.88B | 4.54B | 5.14B | 4.30B | 3.15B | 3.11B | 3.24B | 3.69B |
| Inventory | 6.06B | 5.73B | 5.96B | 7.93B | 7.61B | 6.86B | 7.72B | 8.51B |
| Total assets | 34.62B | 33.47B | 34.68B | 38.61B | 38.49B | 37.00B | 39.91B | 41.77B |
| Total current liabilities | 25.13B | 25.29B | 26.22B | 29.06B | 26.19B | 24.49B | 28.69B | 29.26B |
| Short-term debt | 1.46B | 357.00M | 949.00M | 1.46B | 623.00M | 660.00M | 1.85B | 1.25B |
| Long-term debt | 4.52B | 4.78B | 5.54B | 6.39B | 10.80B | 9.25B | 8.26B | 8.82B |
| Total liabilities | 35,261,000,000.00 | 34,660,000,000.00 | 36,909,000,000.00 | 40,249,000,000.00 | 41,519,000,000.00 | 38,073,000,000.00 | 41,232,000,000.00 | 42,115,000,000.00 |
| Total equity | -639.00M | -1.19B | -2.23B | -1.64B | -3.03B | -1.07B | -1.32B | -346.00M |
| Retained earnings | -473.00M | -818.00M | -1.96B | -2.47B | -4.49B | -2.36B | -2.68B | -2.03B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 19.46B | 20.57B | 22.45B | 22.23B | 23.98B | 26.75B |
| Cash & ST investments | 2.70B | 2.87B | 3.69B | 3.15B | 3.70B | 4.17B |
| Inventory | 8.18B | 8.36B | 8.51B | 8.74B | 9.20B | 10.32B |
| Total assets | 38.80B | 39.85B | 41.77B | 41.54B | 42.94B | 45.70B |
| Total current liabilities | 26.56B | 27.86B | 29.26B | 29.29B | 30.21B | 33.96B |
| Short-term debt | 1.86B | 1.23B | 1.25B | 1.28B | 1.22B | 1.70B |
| Long-term debt | 9.29B | 8.78B | 8.82B | 8.84B | 8.86B | 7.87B |
| Total liabilities | 40,075,000,000.00 | 40,755,000,000.00 | 42,115,000,000.00 | 42,301,000,000.00 | 43,080,000,000.00 | 45,793,000,000.00 |
| Total equity | -1.28B | -901.00M | -346.00M | -766.00M | -144.00M | -92.00M |
| Retained earnings | -2.44B | -2.36B | -2.03B | -2.33B | -1.96B | -2.12B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.53B | 4.65B | 4.32B | 6.41B | 4.46B | 3.57B | 3.75B | 3.70B |
| Depreciation & amortization | 528.00M | 744.00M | 789.00M | 785.00M | 780.00M | 850.00M | 830.00M | 916.00M |
| Free cash flow | 3.98B | 3.98B | 3.74B | 5.83B | 3.70B | 2.98B | 3.16B | 2.80B |
| Dividends paid | -899.00M | -970.00M | -997.00M | -938.00M | -1.04B | -1.04B | -1.08B | -1.09B |
| Stock buybacks / issuance | -2.56B | -2.41B | -3.11B | -6.25B | -4.30B | -100.00M | -2.10B | -850.00M |
| Ending cash balance | 5.17B | 4.54B | 4.86B | 4.30B | 3.15B | 3.23B | 3.25B | 3.71B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 38.00M | 1.66B | 1.62B | 383.00M | 926.00M | 1.74B |
| Depreciation & amortization | 205.00M | 306.00M | 208.00M | 214.00M | 264.00M | 244.00M |
| Free cash flow | -145.00M | 1.45B | 1.43B | 150.00M | 756.00M | 1.55B |
| Dividends paid | -273.00M | -272.00M | -270.00M | -277.00M | -274.00M | -274.00M |
| Stock buybacks / issuance | -100.00M | -150.00M | -500.00M | -325.00M | -100.00M | -300.00M |
| Ending cash balance | 2.73B | 2.87B | 3.71B | 3.15B | 3.70B | 4.17B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| ROA %i | 15.78 | 9.26 | 8.35 | 17.75 | 8.30 | 8.63 | 7.22 | 6.19 |
| ROIC %i | -- | -- | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.69 | 4.71 | 6.13 | 12.23 | 7.62 | 6.74 | 7.26 | 5.83 |
| FCF / sales %i | 6.81 | 6.78 | 6.60 | 9.18 | 5.83 | 5.51 | 5.89 | 5.06 |
| Current ratioi | 0.85 | 0.80 | 0.79 | 0.76 | 0.75 | 0.73 | 0.72 | 0.77 |
| Quick ratioi | 0.55 | 0.53 | 0.52 | 0.45 | 0.38 | 0.39 | 0.40 | 0.42 |
| Debt / assetsi | 17.29 | 15.35 | 21.33 | 22.74 | 31.94 | 29.02 | 27.31 | 26.05 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 10.66 | 11.43 | 14.52 | 30.57 | 13.37 | 5.29 | 6.40 | 5.81 |
| Revenue CAGR (3Y) %i | 4.35 | 6.80 | 2.85 | 2.77 | 2.30 | -1.75 | -5.50 | -4.21 |
| Net income CAGR (3Y) %i | 5.37 | 8.09 | 3.68 | 7.08 | -0.21 | 5.05 | -24.86 | -6.88 |
| FCF CAGR (3Y) %i | 5.17 | 12.21 | 4.49 | 13.53 | -2.44 | -7.28 | -18.48 | -8.86 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | 6.60 | 6.78 | 6.19 | 6.24 | 6.25 | 5.73 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.40 | 5.98 | 5.83 | 5.64 | 5.45 | 5.54 |
| FCF / sales %i | 4.90 | 5.20 | 5.06 | 5.12 | 6.58 | 6.56 |
| Current ratioi | 0.73 | 0.74 | 0.77 | 0.76 | 0.79 | 0.79 |
| Quick ratioi | 0.35 | 0.38 | 0.42 | 0.40 | 0.44 | 0.44 |
| Debt / assetsi | 30.71 | 27.04 | 26.05 | 26.33 | 25.30 | 22.62 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 6.02 | 5.67 | 5.81 | 5.93 | 6.14 | 6.84 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Personal Systems is the largest reported line at 75.06% of revenue, across 3 reported segments.
- The next-largest line, Printing, is a distant second at 24.95% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Personal Systems75.06%
Printing24.95%
Quote time 2026-10-08 07:42:51 · For reference only, not investment advice and not tailored to your situation.